EverHint – Momentum Swing — Aggressive Momentum for May 11, 2026 – 3 Signals – Healthcare Leads (1)

3 signals. Healthcare leads (1). 1 with insider selling. price range $13-$207. sectors: Healthcare (1), Real Estate (1), Technology (1). 1 report earnings within 7 days. full analyst coverage.

What This Signal Is (Quick)

Aggressive Momentum is a momentum swing trading strategy focused on Triple threat: high momentum + high volume + high volatility.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

  • Stock showing strong momentum near or at highs
  • Increased volume confirms institutional interest
  • Breaking out or consolidating near resistance
  • Triple threat: high momentum + high volume + high volatility

Ideal For: Aggressive traders seeking maximum momentum with high risk/reward

Key Criteria:

  • Strong RSI momentum (configurable thresholds)

  • Volume surge above average

  • Price momentum confirmation

  • Minimum ADV: $25M+ (varies by variant)

  • Earnings buffer: 7 days pre/post earnings

  • Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)


📊 Momentum Swing — Aggressive Momentum Signals (3 Total)

Ranked by score:

Rank Ticker Company Sector Last ($) Score Vol Thrust @52w Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 LQDA Liquidia Corporation Healthcare 53.13 0.300 5.36x 0.0% $-18.9M $7.86 4.7
2 TWO Two Harbors Investment... Real Estate 12.62 0.150 3.11x 0.0% $1.17 1.3
3 CAMT Camtek Ltd. Technology 207.46 0.000 2.03x 0.0% 0 $7.64 9.5

Field Notes

Sector concentration: Healthcare (1), Real Estate (1), Technology (1)

Insider selling: LQDA (Liquidia Corporation, $-18.9M)

Near-term earnings: CAMT (Camtek Ltd.) report within 7 days. Higher volatility risk.

Data coverage: 33.3% insider, 0.0% congressional, 33.3% earnings, 100.0% analyst, 0.0% news


Peer Analysis

Understanding how these stocks relate to their industry peers:

TWO (Two Harbors Investment Corp): Leads 5 peers: ARR ($17.72, +0.5%), CIM ($13.44, -1.5%), IVR ($8.19, -0.5%), MFA ($9.63, -2.7%), ORC ($7.02, -0.4%) | Peer of: AGNC ($10.80, -0.6%), AOMR ($8.50, -3.6%), CIM ($13.44, -1.5%) and 13 more

CAMT (Camtek Ltd.): Leads 10 peers: ONTO ($287.52, +1.0%), SMTC ($136.53, +12.1%), ALGM ($48.39, -1.1%), ESE ($297.85, -1.7%), CRUS ($174.23, +1.5%) | Peer of: ALGM ($48.39, -1.1%), BMI ($116.67, -1.6%), CRUS ($174.23, +1.5%) and 5 more

LQDA (Liquidia Corporation): Leads 8 peers: COGT ($34.10, -1.8%), RCUS ($24.86, -2.0%), IBRX ($8.11, -4.7%), DNLI ($19.67, +0.2%), OCUL ($9.28, -3.8%) | Peer of: AGIO ($27.98, +0.7%), AORT ($23.81, -6.3%), COGT ($34.10, -1.8%) and 7 more


Market Context

Major indices are showing modest gains, with the S&P 500 and Dow Jones each up 0.19% and the Nasdaq edging higher by 0.08%, reflecting a mildly bullish trend amid steady risk appetite. However, the VIX's sharp 6.81% rise to 18.36 signals elevated volatility, which can amplify intraday swings—ideal for an aggressive momentum swing strategy seeking quick reversals and extensions. This environment favors capturing short-term momentum bursts, but traders should remain vigilant for potential whipsaws as volatility tempers broader upside momentum.

The overall uptrend supports aggressive entries into momentum plays, yet the VIX spike suggests caution, potentially curbing excessive risk-taking and leading to choppier price action. In such conditions, momentum signals thrive on volatility-fueled breakouts but risk fading if the mild bullish bias weakens. Sector rotation appears tilted toward healthcare as the top performer, implying a defensive shift that could bolster momentum within resilient areas while pressuring cyclical sectors, enhancing selectivity for swing trades.

Sharing Call-to-Action

🔍 If this breakdown was useful, feel free to like, share, or subscribe. Every bit of support matters.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/